Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Cumberland Pharmaceuticals Inc. (CPIX) had Income from Continuous Operations of $-1.95M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$8.29M |
|
$-1.94M |
|
$0.99M |
|
$7.30M |
|
$10.26M |
|
$-1.97M |
|
$0.02M |
|
$-1.94M |
|
$-1.94M |
|
$-1.95M |
|
|
Income from Continuous Operations |
$-1.95M |
$-1.95M |
|
$-1.95M |
|
$-1.97M |
|
$-0.93M |
|
14.96M |
|
14.96M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$29.94M |
|
$0.29M |
|
$35.96M |
|
$65.90M |
|
$24.31M |
|
$5.24M |
|
$15.79M |
|
$40.10M |
|
$25.80M |
|
$9.88M |
|
$25.80M |
|
14.96M |
|
| Cash Flow Statement Financials | |
$4.93M |
|
$-1.63M |
|
$-6.06M |
|
$17.96M |
|
$15.20M |
|
$-2.77M |
|
$0.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.23 |
|
-- |
|
-- |
|
0.17 |
|
0.20 |
|
88.08% |
|
-23.70% |
|
-23.70% |
|
-- |
|
-23.44% |
|
-23.40% |
|
$4.83M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.34 |
|
0.80 |
|
113.21 |
|
-7.55% |
|
-19.74% |
|
-2.96% |
|
-6.28% |
|
$1.73 |
|
$0.32 |
|
$0.33 |
|